Atlas Trials

Clinical Study of Recombinant Novel Coronavirus Vaccine

Clinical trial NCT04466085 · UNKNOWN

Trial details

NCT number
NCT04466085
Sponsor
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Coronavirus
Start date
2020-07-12
Primary completion
2020-10-22
Enrollment
900

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.